Comparing peloid therapy and paraffin treatment for carpal tunnel syndrome
Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome
Beylikduzu State Hospital · NCT06405438
This study is trying to see if peloid therapy or paraffin treatment works better for relieving symptoms in people with mild to moderate carpal tunnel syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Beylikduzu State Hospital (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06405438 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of peloid therapy versus paraffin treatment in patients with mild to moderate carpal tunnel syndrome. A total of 60 patients aged 18-65 will be assessed after receiving either treatment for their condition. Pain and symptom severity will be measured using the Visual Analog Scale (VAS) and the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), along with electrophysiological examinations at baseline, 4 weeks post-treatment, and a 12-week follow-up. The study aims to determine which treatment provides better relief from symptoms and improves nerve function.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 diagnosed with mild to moderate carpal tunnel syndrome experiencing symptoms for at least 3 months.
Not a fit: Patients with neuropathic conditions or those who have had previous injections or surgery for carpal tunnel syndrome may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into more effective non-surgical treatment options for patients with carpal tunnel syndrome.
How similar studies have performed: While similar studies have explored various treatments for carpal tunnel syndrome, the specific comparison of peloid therapy and paraffin treatment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged between 18 and 65 years old. * Patients diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological evaluations. * Patients experiencing symptoms for a minimum of 3 months. Exclusion Criteria: * Patients diagnosed with neuropathic conditions such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome. * Patients with a history of previous injections or surgery for carpal tunnel syndrome.
Where this trial is running
Istanbul
- Beylikdüzü State Hospital — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Principal investigator: Büşra Şirin Ahısha, MD — Beylikdüzü State Hospital
- Study coordinator: Büşra Şirin Ahısha
- Email: bsrn080@gmail.com
- Phone: (0212) 856 27 40
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Carpal Tunnel Syndrome, carpal tunnel syndrome, median neuropathy, median nerve, peloid therapy, mud therapy